FDA Approves Redhouse Productions Variance, Apr 22
Summary
FDA CDRH issued a variance renewal approval letter to Redhouse Productions on April 22, 2024, extending an existing regulatory variance. The variance renewal allows Redhouse Productions to continue operating under modified regulatory terms for the device or activity covered by the original variance. Variance renewals maintain the holder's existing regulatory flexibility while confirming continued compliance with applicable requirements.
About this source
Every FDA document on regulations.gov, the federal rulemaking portal. This is where the agency posts variances, advisory committee meeting notices, draft guidance for comment, citizen petition responses, and procedural rules that do not get a separate Federal Register slot. Around 240 a month. FDA's heavy regulations.gov use means tracking only the Federal Register misses a meaningful chunk of what the agency does day-to-day. Watch this if you manufacture devices, submit IND or NDA applications, run a lab, or advise sponsors on FDA process. GovPing publishes each posting with the docket, document type, division (CDER, CDRH, CFSAN), and comment window where one applies.
What changed
FDA CDRH renewed a variance previously granted to Redhouse Productions, maintaining the regulatory exception that allows the firm to operate under modified requirements for a specific device or activity. The variance renewal approval letter was issued on April 22, 2024, and is associated with docket FDA-2023-V-2753.
Redhouse Productions and other variance holders should monitor the conditions of their approved variances to ensure ongoing compliance and timely renewal applications. Variance approvals are binding regulatory instruments and may be subject to review, modification, or revocation if conditions change or requirements are no longer met.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Content
There are no documents available to view or download
Attachments 1
Variance Renewal Approval Letter from FDA CDRH to Redhouse Productions
More Information
- Author(s) CDRH
Download
Parties
Related changes
Get daily alerts for Regs.gov: Food and Drug Administration
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.